Home » Topics » duke university medical

New anti-clotting drug saves lives in study

PARIS (Reuters) – An experimental anti-clotting drug from Bristol-Myers Squibb and Pfizer saved more lives than standard treatment warfarin in a major study, giving it an edge over rivals in an emerging multibillion-dollar market. Although Eliquis will be third to market among a wave of new oral anticoagulants, the data…

Two-drug obesity therapy finds success in initial study

PARIS (AFP) – A new treatment for obesity that combines two existing drugs resulted in twice as much weight loss as the only approved long-term anti-obesity medication, according to a study released Monday. A mix of Phentermine and topiramate, sold under the brand name of Topamax, was shown in clinical…